CCR5 and cancer: Considering that cancer-FOXP3 has been identified as a biomarker for poor prognosis in NSCLC (107, 108), it is rational to propose that FOXP3-initiated CCL5-CCR5 interactions may also participate in Treg cell migration in NSCLC.